Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of North Central Cancer Treatment Group protocol N0177
- 15 July 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 65 (4) , 1192-1199
- https://doi.org/10.1016/j.ijrobp.2006.01.018
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1Neuro-Oncology, 2006
- Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsNew England Journal of Medicine, 2005
- Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Clinical Cancer Research, 2005
- Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to ErlotinibJNCI Journal of the National Cancer Institute, 2005
- HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes from the HER1/EGFR Inhibitor Rash Management ForumThe Oncologist, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The importance of genomic copy number changes in the prognosis of glioblastoma multiformeNeurosurgical Review, 2003
- Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomasFrontiers in Bioscience-Landmark, 2003
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958